Transchem Share Price | Transchem Stock Screener
TRANSCHEM
Pharmaceuticals
Share Price BSE
₹322.05
▼
-6.55 (-1.99%)
As of July 3, 2026, the Transchem share price (BSE: TRANSCHEM) is ₹322.05, down 1.99% from the previous close, with shares trading between ₹322.05 and ₹335.15, and a 52-week range of ₹39.19–₹356.15.
Analyse Transchem stock price data download and track historical price performance.
Use the Transchem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Transchem Market Cap
₹394.18 Cr.
TRANSCHEM P/E Ratio (TTM)
93.62
Transchem P/B Ratio
4.81
EPS (TTM)
₹3.51
Dividend Yield
-
Debt to Equity
-
TRANSCHEM 52 Week High
₹356.15
Transchem 52 Week Low
₹39.19
Operating Margin
-
Profit Margin
-
TRANSCHEM Revenue (TTM)
-
EBITDA
₹-4.00
Net Income
₹4.00
Total Assets
₹80.00
Total Equity
₹79.00
Transchem Share Price Chart
Screen Transchem share price with an interactive chart. Analyse TRANSCHEM price trends and volatility across different timeframes.
Transchem Company Profile - Fundamental Screener
Screen Transchem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TRANSCHEM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE019B01010
Transchem Balance Sheet Screener
Screen TRANSCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 80 | 76 | 66 | 67 | 63 | 37 | 38 | 37 | 38 | 39 |
| Current Assets | 78 | 67 | 58 | 58 | 55 | 30 | 28 | 30 | 29 | 28 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 5 | 6 | 7 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 79 | 76 | 66 | 66 | 63 | 37 | 38 | 37 | 38 | 38 |
| Share Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves & Surplus | 67 | 63 | 54 | 54 | 51 | 25 | 26 | 25 | 26 | 26 |
Transchem Income Statement Screener - Profit & Revenue Analysis
Screen Transchem income statement and profit fundamentals.
Analyze TRANSCHEM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Transchem share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 11 | 8 | 4 | 7 | 27 | 3 | 3 | 2 | 2 | 2 | 2 |
| Expenses | 4 | 4 | 2 | 2 | 3 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
| EBITDA | -4 | 7 | 6 | 3 | 4 | 25 | 1 | 2 | 0 | 1 | 1 | 1 |
| Operating Profit % | 0.00% | -56.00% | -423.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 6 | 7 | 6 | 3 | 4 | 25 | 1 | 1 | -1 | 0 | 0 | 0 |
| Tax | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 4 | 5 | 4 | 1 | 3 | 24 | 0 | 0 | -1 | 0 | 0 | 0 |
| EPS | 3.51 | 4.27 | 3.43 | 1.01 | 2.34 | 19.73 | 0.33 | 0.25 | -0.97 | -0.18 | 0.04 | 0.10 |
Transchem Cash Flow Screener - Liquidity Fundamentals
Screen TRANSCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 36 | -39 | 1 | 22 | -28 | -1 | 10 | -20 | 1 | 1 |
| Investing Activities | 6 | 5 | -1 | 1 | 23 | 1 | 6 | 20 | -2 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 42 | -34 | 0 | 23 | -5 | 0 | 16 | 0 | -1 | 1 |
Transchem Shareholding Pattern Screener
See Transchem shareholding pattern with promoter, FII, and DII holdings.
Check Transchem promoter holding and ownership changes for TRANSCHEM on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 56.45% | 56.45% | 56.45% | 56.45% | 56.45% | 51.68% | 51.68% | 51.68% |
| FII Holding | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.83% | 24.69% | 24.75% | 23.38% | 21.78% | 27.15% | 27.22% | 27.37% |
| Other Holding | 22.68% | 18.83% | 18.76% | 20.14% | 21.73% | 21.14% | 21.07% | 20.92% |
| Shareholder Count | 13,145 | 13,843 | 13,767 | 13,680 | 13,339 | 13,813 | 13,681 | 13,647 |
Transchem Share Dividend Screener - Share Yield Analysis
Check Transchem dividend history with payout and yield data.
View Transchem dividend details including ex-dates and amounts for TRANSCHEM stock.
Transchem Stock Index Membership
See which indices include Transchem stock.
Check TRANSCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Transchem Market Events Screener - Corporate Actions
Get Transchem corporate actions including splits, bonuses, and buybacks.
Check Transchem stock events that may affect TRANSCHEM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-05 | 2026-05-05 | Quarterly Result Announcement | NA | 1.20% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | -3.29% |
| 2025-12-20 | 2025-12-20 | Extraordinary General Meeting | NA | 126.06% |
| 2025-10-16 | 2025-10-16 | Extraordinary General Meeting | NA | -17.83% |
| 2025-10-16 | 2025-10-16 | Quarterly Result Announcement | NA | -1.48% |
| 2025-08-23 | 2025-08-23 | Annual General Meeting | NA | 15.27% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 2.20% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | -1.96% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -7.99% |
| 2024-10-15 | 2024-10-15 | Quarterly Result Announcement | NA | 9.22% |
| 2024-08-24 | 2024-08-24 | Annual General Meeting | NA | -5.31% |
Transchem Competitors Screener - Peer Comparison
Screen TRANSCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 457,025 | 39.02 | 58,220 | 6.38% | 11,565 | 69.58 |
| Divis Laboratories | 179,377 | 69.00 | 10,560 | 8.73% | 2,520 | 55.41 |
| Torrent Pharmaceuticals | 161,381 | 73.80 | 13,886 | 20.34% | 2,138 | 70.39 |
| Cipla | 117,800 | 30.47 | 29,045 | 2.24% | 3,870 | 66.80 |
| Zydus Life Science | 114,771 | 21.60 | 26,720 | 13.65% | 5,242 | 66.88 |
| Dr Reddys Laboratories | 114,692 | 27.03 | 33,593 | -0.44% | 3,998 | 67.04 |
| Lupin | 113,211 | 20.48 | 27,488 | 19.98% | 5,345 | 71.73 |
| Mankind Pharma | 104,430 | 53.00 | 14,278 | 12.03% | 1,750 | 60.79 |
| Aurobindo Pharma | 93,240 | 25.87 | 33,385 | 3.21% | 3,376 | 70.76 |
| Laurus Labs | 83,262 | 92.55 | 6,868 | 22.01% | 890 | 71.63 |
Transchem Company Announcements - News Screener
Screen TRANSCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-28 | Closure of Trading Window | - |
| 2026-06-05 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-05 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-03 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-06-03 | Board Meeting Outcome for Preferential Issue Committee Meeting Held On June 03 2026 | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-22 | Intimation Of Receipt Of In-Principle Approval For Preferential Issue Of 61500000 Warrants Of Rs. 10/- Each | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-21 | Additional Information Regarding The Preferential Issue Of Warrants By Transchem Limited | - |
| 2026-05-11 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-05-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-05 | Audited Financial Results For The Quarter And Year Ended March 31 2026 | - |
| 2026-05-05 | Board Meeting Outcome for The Meeting Held On May 05 2026 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-04-28 | Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026. | - |
| 2026-04-15 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-07 | Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 Along With Limited Review Report. | - |